Form 4 for OCGN Ocugen, Inc.
Accepted 2023-01-05 00:00:00 ET · period of report 2023-01-03 · accession 0001062993-23-000490 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-05 | 2023-01-03 | OCGN | Upadhyay Arun | CSO | A - Grant | $0.00 | +315.9K | 400.1K | +375% | $0 |
| D | 2023-01-05 | 2023-01-03 | OCGN | Upadhyay Arun | CSO | A - Grant | $0.00 | +379.4K | 379.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-03 | A | A | 315,924 | $0.00 | 400,083 | D | — | — | (F1) Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Ocugen Inc.'s (the "Company's") common stock. The RSUs vest annually in three equal installments commencing on January 3, 2024, subject to continued service with the Company on the applicable vesting dates. The RSUs will be settled on each applicable vesting date in shares of the Company's common stock. |
| 2 | Derivative | Option (Right to Buy) | 2023-01-03 | A | A | 379,357 | $0.00 | 379,357 | D | $1.25 · — to 2033-01-03 | 379,357 Common Stock | (F2) The option vests annually in equal installments over three years commencing on January 3, 2024, subject to continued service with the Company on the applicable vesting dates. |